Last reviewed · How we verify
NCT04959591
Use of Intravenous Acetaminophen in Pediatrics Undergoing Spinal Fusion Surgery
Phase 3 trial testing intravenous acetaminophen in Scoliosis; Adolescence in 99 participants. Completed in 22 April 2022.
15 April 2022
Quick facts
| Lead sponsor | Asan Medical Center |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 99 |
| Start date | 1 June 2021 |
| Primary completion | 15 April 2022 |
| Estimated completion | 22 April 2022 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- intravenous acetaminophen — full drug profile →
- intravenous acetaminophen — full drug profile →
- Placebo
Conditions studied
- Scoliosis; Adolescence — all drugs for Scoliosis; Adolescence →
Sponsor
Asan Medical Center
Who can join
Adults 11 to 20, any sex, with Scoliosis; Adolescence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate whether perioperative intravenous acetaminophen administration reduces postoperative pain and opioid consumption in adolescents and pediatric patients undergoing spinal fusion surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of preemptive and preventive intravenous acetaminophen on opioid consumption in pediatrics undergoing posterior spinal fusion surgery: a randomized controlled trial.
Kim YJ, Kim HJ, Kim S, Kim H, et al · · 2024 · cited 1× · PMID 38383005 · DOI 10.4097/kja.23747
Verify or expand the search:
- PubMed search for NCT04959591
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Scoliosis; Adolescence
Currently open trials in the same condition.
- NCT06242821 — Yoga for Back Pain in Adolescent Scoliosis · NA · recruiting
- NCT06884150 — fNIRS-based Analysis and Evaluation of the Effect of Schroth Rehabilitation on Motor Functions in Adolescent Idiopathic · NA · active not recruiting
- NCT06416579 — Comparison of the Efficiency of Schroth Method and Virtual Reality Exercises in Individuals With AIS · NA · recruiting
- NCT06093477 — Studying Melatonin and Recovery in Teens · NA · recruiting
- NCT05819034 — Conservative Management for Adolescent Idiopathic Scoliosis · NA · recruiting
Other Asan Medical Center trials
Trials by the same sponsor.
- NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
- NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
- NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
- NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
- NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04959591 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
- Last refreshed: 28 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04959591.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing